INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Clinical trial / 2017

Potato protease inhibitor II suppressed postprandial appetite and elevated cholecystokinin in women.

In a randomized crossover trial, 44 healthy women ingested placebo or potato extract standardized to 15 mg or 30 mg potato protease inhibitor II one hour before a 390 kcal breakfast. Both doses significantly lowered postprandial hunger, prospective consumption, and desire to eat while increasing fullness. The 15 mg dose significantly increased plasma cholecystokinin levels over three hours, with no significant differences observed in glucose or insulin.

Study type
Randomized double-blind crossover trial
Who was studied
44 healthy women
What was measured
Postprandial appetite sensations, cholecystokinin, glucose, and insulin

THE PAPER

Potato protease inhibitor II suppresses postprandial appetite in healthy women: a randomized double-blind placebo-controlled trial.

Zhu Y, Lasrado JA, Hu J. Food Funct, 2017.

PubMed 28485429 ↗DOI 10.1039/c6fo01803c ↗

Weight & appetite

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.